Hospital-at-home: buyer beware [See also p 212] There is nothing new about hospital-at-home the arrangement whereby a patient is cared for at home by a team of nurses, physiotherapists and others, rather than occupying a hospital bed. Why, then, is the idea now attracting such close interest from commissioning agencies and trusts alike? One reason is the hope of controlling costs, as hospitals become more and more an environment of expensive high technology; this intermediate type of care might shorten hospital stays for some patients and avoid admission altogether for others. Another driving force is the switch of health service resources towards primary care especially in London, after the Tomlinson recommendations.
Do hospital-at-home schemes save money? Early work on the longest-running service for adults in the UK, in Peterborough, suggested that hospital-at-home was indeed less expensive than care in traditional wards, without worse outcomes. There was, however, huge variation in costs per day and per case, and the economic advantage of hospital-at-home was most clear with early postoperative discharge1'2. More recently in London, Hensher and co-workers3 reached different conclusions from their study of orthopaedic patients; early discharge to hospital-at-home carried no economic advantage. In the interim, however, the time spent by patients in hospital had steadily declined, so the possible gain from enhancement of home care had become smaller (in 1952 the average inpatient stay in hospital was forty-four days; in 1992 it was ten and in acute specialties only about six).
Since what was early discharge ten years ago is now conventional practice, hospital-af-home services that aim for even earlier discharge will be dealing with more complex care and higher dependency. Recognizing the limited potential in this direction, purchasers and providers are turning their attention to hospital-at-home services that avert acute admission. So far, there is no clear evidence that schemes of this sort save resources. We need to look at all costs, including direct and indirect costs to patients, carers and their families as well as those to local health authorities, voluntary agencies and the community at large; this sort of analysis, hitherto neglected, is now being conducted in Leicester, Bristol and Corby. Measurement of these costs is very important, because if large they may present an obstacle to further development of hospital-at-home4 especially where it is meant to deal with acute illness rather than facilitate early discharge from traditional wards. Another barrier, apparently, is antipathy: Fulop and co-workers5 identify resistance to hospital-at-home not only among health care workers but also in some patients.
To measure the level of interest in hospital-at-home services we sent a questionnaire in April 1995 to all 136 health authorities and commissions, or health boards listed in the Health Service Journal's Directory of the NHS (7th edn, August 1994). An introductory letter was addressed to the director of public health (by name), or where no such post was listed to the director of primary care or community care. The recipient was invited to pass the letter on to an appropriate colleague if necessary. 103 agencies (76%) replied 30 health authorities, 59 commissioning agencies, 2 family health authorities making joint responses with a health authority, and 12 health boards. Table 1 shows the types of hospital-at-home reported; and evaluation of these services was either underway or planned as shown in Table 2 .
Two results stand out from these responses. First, despite the lack of information on cost-effectiveness, many agencies now regard hospital-at-home as a viable option for avoiding admission to conventional wards. Second, the number of health authorities who claim to be doing a cost- Health worker satisfaction 18 1 benefit analysis is greater than the number measuring patients' functional ability. How can this be when, especially in older patients, restoration of functional ability after acute illness must be a major outcome measure for cost-benefit analysis? At purchaser level, the lessons about evaluation may not have been learned, in which case hospital-at-home has an uncertain future6. Before embarking on new developments, trust and health authorities would be wise to await evidence from the trials now in progress.
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